News
CHICAGO -- Neoadjuvant nivolumab (Opdivo) plus chemotherapy significantly improved overall survival (OS) compared with ...
HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 ...
Pounding on the bottom of a glass bottle of ketchup is one of life's small annoyances. Getting that sweet, red concoction ...
Safety and Efficacy of Osimertinib in Patients With Non–Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis ...
We developed a novel microfluidic liquid phase nucleic acid purification ... the conventional column-based solid phase nucleic acid extraction method. One step vacuum-driven microfluidics allowed an ...
Phase 1 trial of TIM-3 inhibitor cobolimab monotherapy and in combination with PD-1 inhibitors nivolumab or dostarlimab (AMBER). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I.
aState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China bState Key ...
Abstract: A hybrid phase/current-mode phase interpolator (HPC-PI) is presented to improve phase noise performance of ring oscillator based fractional-N PLLs. The proposed HPC-PI alleviates the ...
An experimental evaluation of the risk of influenza transmission from contaminated objects finds that viable virus was rarely ...
Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in order to keep resources flowing toward its leukemia candidate. The Colorado ...
today announced the dosing of the first U.S. participant in Moderna's Phase 1 study evaluating mRNA-4106, a novel Pan-Tumor Antigen Therapy candidate, in patients with advanced or metastatic solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results